Clinical risk factors for neuroleptic ma
β
Domenico Berardi; Maddalena Dell'Atti; Mario Amore; Diana De Ronchi; Giuseppe Fe
π
Article
π
2002
π
John Wiley and Sons
π
English
β 50 KB
Pharmacological risk factors for neuroleptic malignant syndrome (NMS) are better defined than clinical risk factors. We examined the psychopathological status preceding the onset of NMS in 20 patients. We evaluated four key psychiatric symptoms (psychomotor agitation, catatonia, disorganization and